Use of colostrum from rotavirus-immunised cows as a single feed to prevent rotavirus-induced diarrhoea in calves

Longitudinal study of calf morbidity and mortality on smallholder farms in southern Ethiopia

Calf morbidity and mortality are serious constraints in the success of dairy calf production. Thus, the current study was carried out with the objective to estimate the incidence of calf morbidity and mortality and associated risk factors in milk-shed districts of Gamo Zone, Southern Ethiopia. A prospective cohort and cross-sectional survey were employed from November 2019 to April 2020. A total of 196 calves were recruited by simple random sampling. Recruitment of calves was deployed by both the concurrent and prospective cohorts in calves aged below three months in study herds. The crude incidence of calf morbidity and mortality was 30.9% and 8.64%, respectively. The most frequently encountered disorder was calf diarrhea (10.17%), followed by pneumonia (6.5%). The other disorders were septicemia, omphalitis, arthritis, eye problem and miscellaneous cases. Multivariable Cox regression was revealed significant association for the calf vigor status, colostrum ingestion time, colostrum feeding status, dam parity, age at first calving, and related disorders were found risk factors of calf morbidity; likewise, calf vigor status at birth, time of colostrum ingestion and weaning were risk factors determining calf mortality. Calf morbidity and mortality rates recorded in this study were marginally higher than economically tolerable level, therefore, could affect the productivity of smallholder dairying by decreasing the obtainability of replacement heifers. Among significant explanatory factors investigated, colostrum ingestion time, method and amount were found important determinant factors of calf mortality and morbidity under the small-holder farming in the milk-shed districts of the Gamo zone. Therefore, rigorous calf husbandry practice is a need to manipulate the aforementioned calf determinants with subsequent application of tailor-made interventions.

Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems

Immunisation by administration of antibodies (immunoglobulins) has been known for more than one hundred years as a very efficient means of obtaining immediate, short-lived protection against infection and/or against the disease-causing effects of toxins from microbial pathogens and from other sources. Thus, due to its rapid action, passive immunisation is often used to treat disease caused by infection and/or toxin exposure. However immunoglobulins may also be administered prior to exposure to infection and/or toxin, although they will not provide long-lasting protection as is seen with active immunisation (vaccination) in which an immunological memory is established by controlled exposure of the host to the pathogen in question. With multi-factorial infectious diseases in production animals, especially those that have proven hard to control by vaccination, the potential of passive immunisation remains big. This review highlights a number of examples on the use of passive immunisation for the control of infectious disease in the modern production of a range of animals, including pigs, cattle, sheep, goat, poultry and fish. Special emphasis is given on the enablement of passive immunisation strategies in these production systems through low cost and ease of use as well as on the sources, composition and purity of immunoglobulin preparations used and their benefits as compared to current measures, including vaccination (also comprising maternal vaccination), antibiotics and feed additives such as spray-dried plasma. It is concluded that provided highly efficient, relatively low-price immunoglobulin products are available, passive immunisation has a clear role in the modern animal production sector as a means of controlling infectious diseases, importantly with a very low risk of causing development of bacterial resistance, thus constituting a real and widely applicable alternative to antibiotics.

Calf health from birth to weaning. II. Management of diarrhoea in pre-weaned calves

Calfhood diseases have a major impact on the economic viability of cattle operations. The second of this three part review series considers the management of diarrhoeic diseases in pre-weaned calves. In neonatal calf diarrhoea, oral rehydration therapy is the single most important therapeutic measure to be carried out by the farmer and is usually successful if instigated immediately after diarrhoea has developed. Continued feeding of milk or milk replacer to diarrhoeic calves is important, to prevent malnourishment and weight loss in affected calves. Indiscriminative antibiotic treatment of uncomplicated diarrhoea is discouraged, whereas systemically ill calves can benefit from systemic antibiotic treatment for the prevention of septicaemia or concurrent diseases. Ancillary treatments and specific preventive measures are discussed. Eimeriosis has a high economic impact on the farming industries due to direct cost of treatment and calf losses, but especially due to decreased performance of clinically as well as sub-clinically affected animals. Emphasis lies on prophylactic or metaphylactic treatment, since the degree of damage to the intestinal mucosa once diarrhoea has developed, makes therapeutic intervention unrewarding.

Calf morbidity and mortality in smallholder dairy farms in Ada'a Liben district of Oromia, Ethiopia

A longitudinal observational study on calf morbidity and mortality was conducted in smallholder dairy farms in Ada'a Liben district of Oromia, Ethiopia. A total of 185 calves from 112 market oriented smallholder dairy farms were selected randomly and regularly monitored for clinical health problems up to six months of age. Information on potential risk factors was collected by personal observation during the regular visit to farms and from questionnaire survey conducted during the study period. The overall incidences of crude morbidity and crude mortality were 62% and 22%, respectively. The most frequent disease syndrome was calf diarrhea with the incidence of 39% followed by joint ill 6%. The other disease conditions/syndromes diagnosed include navel ill, pneumonia, septicemic conditions, congenital problems and miscellaneous cases. Age of the calves, age at first colostrum ingestion and cleanness of the calf barns significantly influenced morbidity. Older calves (greater than three months of age) were at lower risk of crude morbidity than younger calves (less than three months of age) (HR = 0.42, P = 0.001). Higher risk of crude morbidity was observed in calves that ingested their first colostrum meal later than 6 hours of age compared to those that ingested colostrum earlier (HR = 2.24, P = 0.001). Similarly, calves housed in unclean barns were at higher risk of morbidity than calves housed in clean barns (HR = 1.75, P = 0.024). Of the 20 potential risk factors investigated, age was the only factor that was found significantly associated with mortality (HR = 0.04, P = 0.001). Calves older than three months of age were at lower risk of mortality than younger calves.

Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines

Triple-layered virus-like particles (VLPs) were produced in a baculovirus expression system from the two prevalent bovine rotavirus (BRV) serotypes, IND (P[5]G6) and 2292B (P[11]G10). Five groups of pregnant cows were inoculated intramuscularly and intramammarily with IND VLPs [BRV RF VP2, and IND VP4, 6, and 7, 250 microg per dose], 2292B VLPs [RF VP2, Cr VP4 (P[11]), and 2292B VP6 and 7, 250 microg per dose], combined IND/2292B VLPs (125 microg each VLP per dose), inactivated IND BRV (5x10(7)PFU per dose, pre-inactivation), or cell supernatant (mock-controls) in incomplete Freund's adjuvant. Serum, colostrum and milk were collected and tested for isotype-specific antibodies, and homologous and heterologous neutralizing antibodies (VN) to BRV by ELISA and VN tests, respectively. After vaccination, the IgG1 and homologous VN geometric mean antibody titers (GMTs) to BRV in serum of vaccinated groups were significantly (P<0.05) higher than in the mock-controls through postpartum day (PPD) 30. In colostrum, the IgG1 and IgA, and the homologous and heterologous VN GMTs of the IND VLP, 2292B VLP, combined IND/2292B VLP and the inactivated IND groups were significantly enhanced compared to the mock-controls, except for the heterologous VN GMTs in the inactivated IND group. However, the VLP vaccine groups had significantly higher homologous and heterologous VN GMTs than the inactivated IND group. The VN GMTs of the IND/2292B VLP group were statistically similar to the homologous VN GMTs of the IND or 2292B VLP groups, although the IgG1 GMT was lower. In milk, the IgG1 and homologous VN GMTs of the VLP groups were significantly higher than the inactivated IND or the mock-control groups through PPD30. However, the heterologous and homologous VN GMTs of inactivated IND group were statistically similar to the mock-control group at PPD0 and 30, respectively. These results demonstrate that the BRV antibody titers in serum, colostrum and milk are significantly enhanced by the use of triple-layered VLPs and inactivated IND vaccines, but significantly higher antibody responses were observed in the VLP vaccinated cows. The combined IND/2292B VLP vaccine induced comparable VN responses to BRV in serum, colostrum and milk compared to those induced by the individual IND or 2292B VLP vaccines, suggesting that at least two different serotypes can be mixed to confer maximum antibody responses to the incorporated serotypes.